The FDA’s Center for Biologics Evaluation and Research granted Breakthrough Device Designation for the SCD in cardiorenal ...
Novant Health gathered with members of the community to celebrate the completion of the new five-story, 193,000-square-foot ...
Study to be conducted under $3.6 million NIH grant DENVER, Jan. 13, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), ...
Hospitals with a higher volume of percutaneous microaxial ventricular assist device implantation in the US have fewer deaths among cardiogenic shock patients.
The global cardiac assist devices market is set to grow significantly over the next decade, with its valuation projected to ...
Detailed price information for Seastar Medical Hldg Corp (ICU-Q) from The Globe and Mail including charting and trades.
4d
The Heart Failure Society of America, in partnership with Elsevier, is proud to announce the appointment of Jason N. Katz MD, ...
The ARIES-HM3 trial analysis found that in advanced heart failure patients with traditional indications for antiplatelet ...
Cardiologists at UC Davis Health are among the first in the country to use a novel, low-profile device to improve blood flow ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback